enhanced performance of the nodify xl2 blood-based lung nodule test
Published 3 years ago • 641 plays • Length 36:00Download video MP4
Download video MP3
Similar videos
-
2:01
what does the nodify xl2 test measure?
-
1:01:35
webinar replay: evolution of clinical evidence of the blood-based nodify lung nodule risk assessment
-
42:15
optimizing diagnosis of malignant lung nodules with the use of biomarker testing and robotic bronch
-
2:20
how does nodify lung™ testing work?
-
52:55
using a blood-based biomarker in patients with pulmonary nodules in a real-world observational study
-
3:18
case studies using nodify lung™ testing
-
3:21
the importance of nodify
-
28:50
evaluating lung nodules during the covid-19 pandemic using blood-based biomarkers
-
32:54
reclassifying malignancy risk in indeterminate pulmonary nodules using nodify lung™ testing strategy
-
1:47
what does the nodify cdt test measure?
-
59:09
the use of blood-based biomarkers in the evaluation and management of pulmonary nodules
-
1:01:10
webinar replay: standardizing use of diagnostic tests in lung cancer
-
59:03
importance of apps in comprehensive lung nodule programs using the nodify lung® testing strategy
-
3:15
nodify lung collection video – 2021
-
48:52
using biomarker-based risk assessments to inform lung nodule referral decisions
-
56:13
building a nodule program & the role of biodesix testing
-
0:46
3 common myths about lung cancer w/ dr. eric singhi
-
49:46
dr. sonali sethi_march'24 webinar_efficiently diagnosing lung cancer
-
0:39
the importance of monitoring lung nodules